Published in Retrovirology on November 10, 2009
T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules. Cytokine (2011) 0.92
HTLV-1 p13, a small protein with a busy agenda. Mol Aspects Med (2010) 0.87
Proteome analysis of sheep B lymphocytes in the course of bovine leukemia virus-induced leukemia. Exp Biol Med (Maywood) (2017) 0.75
Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol (2006) 21.58
Free radicals in the physiological control of cell function. Physiol Rev (2002) 19.62
Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med (2001) 11.92
Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol (2000) 6.49
Biology of disease: free radicals and tissue injury. Lab Invest (1982) 6.09
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer (2007) 4.69
Glutathione deficiency and human immunodeficiency virus infection. Lancet (1992) 2.25
Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage. Mol Carcinog (1990) 2.24
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology (2007) 1.71
In vivo infection of sheep by bovine leukemia virus mutants. J Virol (1993) 1.69
Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy. Mol Nutr Food Res (2009) 1.38
Pathobiology of bovine leukemia virus. Vet Res (1994) 1.26
Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer. Vet Microbiol (1988) 1.23
Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4. Retrovirology (2009) 1.16
Oxidative damage and cancer. Am J Pathol (2002) 1.12
Both wild-type and strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells from apoptosis. J Virol (1997) 1.11
Experimental transmission of enzootic bovine leukosis to sheep: latency period of the tumoral disease. Leukemia (1988) 1.03
Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo. Proc Natl Acad Sci U S A (2005) 1.02
Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep. Proc Natl Acad Sci U S A (2002) 1.01
Peripheral blood B-cell death compensates for excessive proliferation in lymphoid tissues and maintains homeostasis in bovine leukemia virus-infected sheep. J Virol (2006) 0.99
Redox modulation of tyrosine phosphorylation-dependent signal transduction pathways. Free Radic Biol Med (1996) 0.99
Coexpression of adult T-cell leukemia-derived factor, a human thioredoxin homologue, and human papillomavirus DNA in neoplastic cervical squamous epithelium. Cancer (1991) 0.99
Modulation of mitochondrial K(+) permeability and reactive oxygen species production by the p13 protein of human T-cell leukemia virus type 1. Biochim Biophys Acta (2009) 0.97
Bovine leukaemia virus-induced lymphocytosis in sheep is associated with reduction of spontaneous B cell apoptosis. J Gen Virol (1997) 0.97
Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load. J Virol (1999) 0.97
Redox-sensing release of human thioredoxin from T lymphocytes with negative feedback loops. J Immunol (2004) 0.97
Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells. Br J Haematol (2008) 0.97
Bovine leukemia virus (BLV)-infected B-cells express a marker similar to the CD5 T cell marker. Immunol Lett (1989) 0.96
CD5+ B cells from bovine leukemia virus infected cows are activated cycling cells responsive to interleukin 2. Leukemia (1992) 0.96
ADF, a growth-promoting factor derived from adult T cell leukemia and homologous to thioredoxin: involvement in lymphocyte immortalization by HTLV-I and EBV. Adv Cancer Res (1991) 0.95
Control of cell death pathways by HTLV-1 proteins. Front Biosci (Landmark Ed) (2009) 0.93
HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F-p73 pathway. Oncogene (2004) 0.93
Valproic acid-induced gene expression through production of reactive oxygen species. Cancer Res (2006) 0.91
Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I Tax. Immunol Lett (1996) 0.89
Retracted Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. J Virol (2004) 0.86
Thioredoxin overexpression in mice, model of attenuation of oxidative stress, prevents benzene-induced hemato-lymphoid toxicity and thymic lymphoma. Exp Hematol (2006) 0.84
Spleen-dependent turnover of CD11b peripheral blood B lymphocytes in bovine leukemia virus-infected sheep. J Virol (2006) 0.83
Anti-apoptotic activity of the glutathione peroxidase homologue encoded by HIV-1. Apoptosis (2004) 0.83
Reactive oxygen species mediate N-(4-hydroxyphenyl)retinamide-induced cell death in malignant T cells and are inhibited by the HTLV-I oncoprotein Tax. Leukemia (2006) 0.81
Epstein-Barr virus-infected Akata cells are sensitive to histone deacetylase inhibitor TSA-provoked apoptosis. J Biochem Mol Biol (2005) 0.79
Involvement of glutathione as a mechanism of indirect protection against spontaneous ex vivo apoptosis associated with bovine leukemia virus. J Virol (2004) 0.78
[EBV-related malignancies and thioredoxin]. Nihon Rinsho (1997) 0.77
Effects of hydrogen peroxide on bovine leukemia virus expression. Biol Chem (2003) 0.76
The HTLV-1 Tax interactome. Retrovirology (2008) 2.02
Reduction of B cell turnover in chronic lymphocytic leukaemia. Br J Haematol (2008) 1.74
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology (2007) 1.71
Lymphocyte kinetics: the interpretation of labelling data. Trends Immunol (2002) 1.44
Quantifying lymphocyte kinetics in vivo using carboxyfluorescein diacetate succinimidyl ester (CFSE). Proc Biol Sci (2006) 1.24
Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses. Retrovirology (2012) 1.16
Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV. Viruses (2011) 1.14
Cell dynamics and immune response to BLV infection: a unifying model. Front Biosci (2007) 1.13
Interaction of retroviral Tax oncoproteins with tristetraprolin and regulation of tumor necrosis factor-alpha expression. J Natl Cancer Inst (2003) 1.08
Oncoviral bovine leukemia virus G4 and human T-cell leukemia virus type 1 p13(II) accessory proteins interact with farnesyl pyrophosphate synthetase. J Virol (2002) 1.04
Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo. Proc Natl Acad Sci U S A (2005) 1.02
Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep. Proc Natl Acad Sci U S A (2002) 1.01
Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma. Clin Cancer Res (2009) 1.01
Peripheral blood B-cell death compensates for excessive proliferation in lymphoid tissues and maintains homeostasis in bovine leukemia virus-infected sheep. J Virol (2006) 0.99
Fate of premalignant clones during the asymptomatic phase preceding lymphoid malignancy. Cancer Res (2005) 0.99
Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1. Proc Natl Acad Sci U S A (2004) 0.99
Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients. Blood (2007) 0.98
Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSP T lymphocytes. Blood (2011) 0.98
Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo. J Virol (2002) 0.98
Safety of long-term treatment of HAM/TSP patients with valproic acid. Blood (2011) 0.97
Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection. PLoS Pathog (2013) 0.97
Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells. Br J Haematol (2008) 0.97
Subcellular localization of the bovine leukemia virus R3 and G4 accessory proteins. J Virol (2002) 0.97
Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy. Eur J Cancer (2010) 0.94
Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response. Exp Hematol (2007) 0.94
Interaction of HTLV-1 Tax with minichromosome maintenance proteins accelerates the replication timing program. Blood (2011) 0.92
Reduced proviral loads during primo-infection of sheep by Bovine Leukemia virus attenuated mutants. Retrovirology (2004) 0.92
Even attenuated bovine leukemia virus proviruses can be pathogenic in sheep. J Virol (2007) 0.91
Bioreactor mixing efficiency modulates the activity of a prpoS::GFP reporter gene in E. coli. Microb Cell Fact (2009) 0.88
Measurement of ribosomal RNA turnover in vivo by use of deuterium-labeled glucose. Clin Chem (2009) 0.88
How the DNA damage response determines the fate of HTLV-1 Tax-expressing cells. Retrovirology (2012) 0.87
How HTLV-1 may subvert miRNAs for persistence and transformation. Retrovirology (2008) 0.87
The role of epigenetics in malignant pleural mesothelioma. Lung Cancer (2013) 0.87
Emphasis on cell turnover in two hosts infected by bovine leukemia virus: a rationale for host susceptibility to disease. Vet Immunol Immunopathol (2008) 0.86
Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling. Blood (2006) 0.85
Reduced cell turnover in bovine leukemia virus-infected, persistently lymphocytotic cattle. J Virol (2003) 0.85
Chromatin disruption in the promoter of bovine leukemia virus during transcriptional activation. Nucleic Acids Res (2011) 0.84
Spleen-dependent turnover of CD11b peripheral blood B lymphocytes in bovine leukemia virus-infected sheep. J Virol (2006) 0.83
Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1. Oncogene (2005) 0.82
Earlier onset of delta-retrovirus-induced leukemia after splenectomy. PLoS One (2009) 0.81
Viral expression directs the fate of B cells in bovine leukemia virus-infected sheep. J Virol (2011) 0.81
In vivo ribosomal RNA turnover is down-regulated in leukaemic cells in chronic lymphocytic leukaemia. Br J Haematol (2010) 0.80
Acetylation at lysine 346 controls the transforming activity of the HTLV-1 Tax oncoprotein in the Rat-1 fibroblast model. Retrovirology (2013) 0.79
Gene activation therapy: from the BLV model to HAM/TSP patients. Front Biosci (Schol Ed) (2009) 0.79
Involvement of glutathione as a mechanism of indirect protection against spontaneous ex vivo apoptosis associated with bovine leukemia virus. J Virol (2004) 0.78
The homeobox protein MSX2 interacts with tax oncoproteins and represses their transactivation activity. J Biol Chem (2005) 0.78
WIP1 deficiency inhibits HTLV-1 Tax oncogenesis: novel therapeutic prospects for treatment of ATL? Retrovirology (2012) 0.77
Protein-protein interactions and gene expression regulation in HTLV-1 infected cells. Front Biosci (Landmark Ed) (2009) 0.77
Application of temperature-gradient gel electrophoresis for detection of prion protein gene polymorphisms in Polish Swiniarka sheep. J Vet Diagn Invest (2006) 0.76
Development of a 1-step enzyme-linked immunosorbent assay for the rapid diagnosis of bovine respiratory syncytial virus in postmortem specimens. J Vet Diagn Invest (2007) 0.76
Comparison of PCR methods for the detection of genetic variants of carp edema virus. Dis Aquat Organ (2017) 0.75
Facilitating studies of cell proliferation in chronic lymphocytic leukemia. Leuk Res (2010) 0.75
An eYFP reporter gene for the yeast two-hybrid system. Protein J (2013) 0.75